Table 1.
Human Cell Lines Responsive to Interferon-Lambda Treatment
| Tumor type | Cell line | Reference |
|---|---|---|
| Bladder carcinoma | T24/83 | Meager and others (2005) |
| Burkitt's lymphoma | Raji | Zhou and others (2007) |
| Cervical carcinoma | HeLa S3 | Kotenko and others (2003) |
| Colorectal adenocarcinoma | HT29, SW480 | Li and others (2008), Brand and others (2005), Kotenko and others (2003) |
| Colorectal carcinoma | HCT116 | Brand and others (2005) |
| Glioblastoma | LN229, LN319 | Meager and others (2005) |
| Hepatocellular carcinoma | HepG2, Huh-7 | Ank and others (2006), Marcello and others (2006) |
| Hepatoma | PEB8 | Hong and others (2007) |
| Keratinocyte carcinoma | HaCaT | Maher and others (2008) |
| Laryngeal carcinoma | Hep2C | Meager and others (2005) |
| Lung carcinoma | A549 | Kotenko and others (2003) |
| Melanoma | 1106 MEL, A375, F01 | Guenterberg and others (2010) |
| Esophageal carcinoma | T.Tn, TE-2, TE-4, TE-10, TE-12, YES-2, YES-4, YES-5 | Li and others (2010) |
| Osteosarcoma | MG63 | Meager and others (2005) |
| Pancreatic neuroendocrine carcinoma | BON1 | Zitzmann and others (2006) |